In order for an expedited FDA-approved product to be successful, products likely need a robust data package in which multiple clinical endpoints prove ultimate clinical benefit
Consider requesting an exception If you dont meet your health plans criteria for a GLP-1 medication, you may still have options
If you are considering it and the cost is not a barrier, it is unlikely to harm you and may provide a small benefit
Failure to protect against myocardial ischemia-reperfusion injury with sevoflurane postconditioning in old rats in vivo
He says while a plateauing of weight-loss is seen in Mounjaro (tirzepatide) at around 10-12 weeks and semaglutide plateaued at around 45-50 weeks, retatrutide showed weight-reduction benefits even after 68 weeks, the end time for the clinical trial
It is the same logic as a loading phase followed by a maintenance phase in many research protocols: front-load to establish, then hold with less